annual EBITDA:
-$212.63M+$125.58M(+37.13%)Summary
- As of today (September 16, 2025), TVTX annual EBITDA is -$212.63 million, with the most recent change of +$125.58 million (+37.13%) on December 31, 2024.
- During the last 3 years, TVTX annual EBITDA has fallen by -$99.74 million (-88.35%).
- TVTX annual EBITDA is now -30375471.43% below its all-time high of -$700.00, reached on February 28, 2011.
Performance
TVTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$1.37M+$31.24M(+104.57%)Summary
- As of today (September 16, 2025), TVTX quarterly EBITDA is $1.37 million, with the most recent change of +$31.24 million (+104.57%) on June 30, 2025.
- Over the past year, TVTX quarterly EBITDA has increased by +$58.07 million (+102.41%).
- TVTX quarterly EBITDA is now at all-time high.
Performance
TVTX quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$120.53M+$58.07M(+32.51%)Summary
- As of today (September 16, 2025), TVTX TTM EBITDA is -$120.53 million, with the most recent change of +$58.07 million (+32.51%) on June 30, 2025.
- Over the past year, TVTX TTM EBITDA has increased by +$152.16 million (+55.80%).
- TVTX TTM EBITDA is now -30133400.00% below its all-time high of -$400.00, reached on May 1, 2008.
Performance
TVTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
TVTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +37.1% | +102.4% | +55.8% |
| 3 y3 years | -88.3% | +102.6% | +21.8% |
| 5 y5 years | -167.8% | +110.5% | -128.7% |
TVTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -88.3% | +37.1% | at high | +101.6% | at high | +61.5% |
| 5 y | 5-year | -328.8% | +37.1% | at high | +101.6% | -162.8% | +61.5% |
| alltime | all time | <-9999.0% | +37.1% | at high | +101.6% | <-9999.0% | +61.5% |
TVTX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $1.37M(-104.6%) | -$120.53M(-32.5%) |
| Mar 2025 | - | -$29.87M(-36.8%) | -$178.61M(-16.0%) |
| Dec 2024 | -$212.63M(-37.1%) | -$47.24M(+5.5%) | -$212.63M(-10.0%) |
| Sep 2024 | - | -$44.79M(-21.0%) | -$236.37M(-13.3%) |
| Jun 2024 | - | -$56.71M(-11.2%) | -$272.70M(-5.3%) |
| Mar 2024 | - | -$63.89M(-10.0%) | -$287.83M(-6.3%) |
| Dec 2023 | -$338.21M(+13.1%) | -$70.99M(-12.5%) | -$307.08M(-2.0%) |
| Sep 2023 | - | -$81.11M(+12.9%) | -$313.50M(+1.5%) |
| Jun 2023 | - | -$71.84M(-13.6%) | -$308.84M(+6.7%) |
| Mar 2023 | - | -$83.15M(+7.4%) | -$289.44M(+13.0%) |
| Dec 2022 | -$299.09M(+164.9%) | -$77.40M(+1.2%) | -$256.25M(+16.1%) |
| Sep 2022 | - | -$76.45M(+45.8%) | -$220.68M(+43.1%) |
| Jun 2022 | - | -$52.44M(+5.0%) | -$154.20M(+19.6%) |
| Mar 2022 | - | -$49.96M(+19.4%) | -$128.95M(+15.3%) |
| Dec 2021 | -$112.89M(+127.6%) | -$41.83M(+319.4%) | -$111.88M(+26.2%) |
| Sep 2021 | - | -$9.97M(-63.3%) | -$88.63M(+2.4%) |
| Jun 2021 | - | -$27.19M(-17.3%) | -$86.56M(+19.6%) |
| Mar 2021 | - | -$32.89M(+77.0%) | -$72.35M(+42.4%) |
| Dec 2020 | -$49.59M(-37.5%) | -$18.58M(+134.9%) | -$50.80M(+10.8%) |
| Sep 2020 | - | -$7.91M(-39.0%) | -$45.86M(-13.0%) |
| Jun 2020 | - | -$12.97M(+14.5%) | -$52.72M(-22.6%) |
| Mar 2020 | - | -$11.33M(-17.0%) | -$68.08M(-14.3%) |
| Dec 2019 | -$79.40M(+58.7%) | -$13.65M(-7.6%) | -$79.40M(+3.6%) |
| Sep 2019 | - | -$14.76M(-47.9%) | -$76.66M(+0.8%) |
| Jun 2019 | - | -$28.34M(+25.1%) | -$76.08M(+21.7%) |
| Mar 2019 | - | -$22.66M(+107.8%) | -$62.50M(+25.6%) |
| Dec 2018 | -$50.02M(+382.6%) | -$10.90M(-23.1%) | -$49.78M(+25.6%) |
| Sep 2018 | - | -$14.18M(-3.9%) | -$39.63M(+53.1%) |
| Jun 2018 | - | -$14.76M(+48.5%) | -$25.88M(+52.2%) |
| Mar 2018 | - | -$9.94M(+1216.2%) | -$17.00M(+22.8%) |
| Dec 2017 | -$10.37M | -$755.00K(+74.8%) | -$13.84M(-29.0%) |
| Sep 2017 | - | -$432.00K(-92.6%) | -$19.49M(-21.6%) |
| Jun 2017 | - | -$5.88M(-13.3%) | -$24.86M(+5.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | -$6.78M(+6.0%) | -$23.61M(+27.7%) |
| Dec 2016 | -$18.48M(-2.0%) | -$6.40M(+10.1%) | -$18.48M(+11.6%) |
| Sep 2016 | - | -$5.81M(+25.7%) | -$16.56M(+5.1%) |
| Jun 2016 | - | -$4.62M(+179.3%) | -$15.76M(+11.3%) |
| Mar 2016 | - | -$1.66M(-63.0%) | -$14.15M(-24.8%) |
| Dec 2015 | -$18.87M(-74.6%) | -$4.47M(-10.6%) | -$18.82M(-39.6%) |
| Sep 2015 | - | -$5.00M(+65.9%) | -$31.19M(-34.7%) |
| Jun 2015 | - | -$3.02M(-52.3%) | -$47.77M(-25.0%) |
| Mar 2015 | - | -$6.33M(-62.4%) | -$63.70M(-13.8%) |
| Dec 2014 | -$74.41M(+203.0%) | -$16.84M(-22.0%) | -$73.89M(+7.3%) |
| Sep 2014 | - | -$21.59M(+14.0%) | -$68.87M(+32.2%) |
| Jun 2014 | - | -$18.94M(+14.6%) | -$52.08M(+45.1%) |
| Mar 2014 | - | -$16.52M(+39.9%) | -$35.90M(+66.4%) |
| Dec 2013 | -$24.56M(-18.5%) | -$11.82M(+146.1%) | -$21.58M(-45.9%) |
| Sep 2013 | - | -$4.80M(+73.8%) | -$39.88M(+13.7%) |
| Jun 2013 | - | -$2.76M(+25.7%) | -$35.08M(+8.5%) |
| Mar 2013 | - | -$2.20M(-92.7%) | -$32.32M(+7.3%) |
| Dec 2012 | -$30.13M(>+9900.0%) | -$30.12M(<-9900.0%) | -$30.12M(>+9900.0%) |
| Nov 2011 | - | $0.00(0.0%) | -$600.00(-14.3%) |
| Aug 2011 | - | $0.00(0.0%) | -$700.00(0.0%) |
| May 2011 | - | $0.00(-100.0%) | -$700.00(0.0%) |
| Feb 2011 | -$700.00(-53.3%) | -$600.00(+500.0%) | -$700.00(+40.0%) |
| Nov 2010 | - | -$100.00(<-9900.0%) | -$500.00(+25.0%) |
| Aug 2010 | - | $0.00(0.0%) | -$400.00(-20.0%) |
| May 2010 | - | $0.00(-100.0%) | -$500.00(-66.7%) |
| Feb 2010 | -$1500.00(+7.1%) | -$400.00(<-9900.0%) | -$1500.00(+66.7%) |
| Nov 2009 | - | $0.00(-100.0%) | -$900.00(-57.1%) |
| Aug 2009 | - | -$100.00(-90.0%) | -$2100.00(+5.0%) |
| May 2009 | - | -$1000.00(-600.0%) | -$2000.00(+42.9%) |
| Feb 2009 | -$1400.00(-97.3%) | $200.00(-116.7%) | -$1400.00(-12.5%) |
| Nov 2008 | - | -$1200.00(<-9900.0%) | -$1600.00(+300.0%) |
| Aug 2008 | - | $0.00(-100.0%) | -$400.00(0.0%) |
| May 2008 | - | -$400.00 | -$400.00 |
| Feb 2008 | -$52.00K | - | - |
FAQ
- What is Travere Therapeutics, Inc. annual EBITDA?
- What is the all time high annual EBITDA for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Travere Therapeutics, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Travere Therapeutics, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Travere Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of TVTX is -$212.63M
What is the all time high annual EBITDA for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high annual EBITDA is -$700.00
What is Travere Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, TVTX annual EBITDA has changed by +$125.58M (+37.13%)
What is Travere Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of TVTX is $1.37M
What is the all time high quarterly EBITDA for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high quarterly EBITDA is $1.37M
What is Travere Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, TVTX quarterly EBITDA has changed by +$58.07M (+102.41%)
What is Travere Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of TVTX is -$120.53M
What is the all time high TTM EBITDA for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high TTM EBITDA is -$400.00
What is Travere Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, TVTX TTM EBITDA has changed by +$152.16M (+55.80%)